List Bio breaks ground on $125M Fishers facility

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

List Biotherapeutics Inc. has broken ground on a 110,000-square-foot contract manufacturing facility in Fishers. The company announced plans last fall to invest $125 million to build a laboratory and production plant in the Fishers Life Science and Innovation Park.

List Bio says it plans to hire 210 employees for the Fishers facility.

The company, a subsidiary of South Korea-based Genome & Co., specializes in biologics manufacturing. The facility will produce microbiomes, a beneficial bacteria used to target a variety of diseases or conditions.

The company says the facility will offer an end-to-end manufacturing solution from early-stage development to late-stage clinical trials and commercialization in the pharmaceutical space.

Construction is expected to be complete by the end of 2023.